eptinezumab
Generic: ALD403·Brand: Vyepti·Code: ALD403
eptinezumab: sourced relationships with 1 company · 2 clinical trials tracked.
eptinezumab evidence translation
What we can confirm
2 tracked trials
What it means
Source-backed records connect eptinezumab to ALDR; that link alone does not prove the drug works.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
How could eptinezumab → ALDR affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| ALDER BIOPHARMACEUTICALS INC (ALDR) prevention of migraine | BLA Filed |
Clinical Trial Registry Records (2)
Migraine Medication Effects on Urinary Symptoms
NCT06212661Registry updated 2025-10-01
Primary endpoint: changes in OAB symptoms
Observational200 targetStarted 2024-04Completion 2026-121 site · United StatesThe Cleveland Clinic
China HeadAche DIsorders RegiStry
NCT05334927Registry updated 2026-07-10
Primary endpoint: Headache Days
Observational10,000 targetStarted 2022-08Completion 2032-1250 sites · ChinaBeijing Tiantan Hospital
Frequently asked questions
Which companies have sourced relationships with eptinezumab?
eptinezumab has dated SEC/FDA relationship records for ALDER BIOPHARMACEUTICALS INC.
How many clinical trials involve eptinezumab?
BioSniper tracks 2 clinical trials involving eptinezumab.